BioCentury
ARTICLE | Company News

Chiroscience, Astra AB, Zeneca Group PLC deal

March 29, 1999 8:00 AM UTC

CRO and Zeneca reached final agreement on the return of Chirocaine levobupivacaine to CRO as a result of Zeneca's merger with Astra (see BioCentury, Dec. 14, 1998). Zeneca will pay CRO £10 million ($...